A Phase 1 Study to Evaluate the Pharmacokinetics of Roxadustat in Subjects With Different Degrees of Renal Function
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Roxadustat (Primary)
- Indications Renal failure
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Europe Ltd
- 09 Nov 2020 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 19 Oct 2020 According to a FibroGen media release, data form this study will be presented at the American Society of Nephrology (ASN) Kidney Week 2020.
- 08 Jun 2020 According to an Astellas Pharma media release, results from this study were presented at the European Renal Association-European Dialysis and Transplant Association Virtual Congress 2020.